Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LAM-181 by Laminar Pharmaceuticals for Neuropathic Pain (Neuralgia): Likelihood of Approval
LAM-181 is under clinical development by Laminar Pharmaceuticals and currently in Phase II for Neuropathic Pain (Neuralgia). According to GlobalData,...